Karonudib is a promising anticancer therapy in hepatocellular carcinoma

Hua, X., Sanjiv, K., Gad, H. et al. (11 more authors) (2019) Karonudib is a promising anticancer therapy in hepatocellular carcinoma. Therapeutic Advances in Medical Oncology, 11. ISSN 1758-8359

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s), 2019. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: cancer; cancer treatment; hepatocellular carcinoma; MTH1; reactive oxygen species
Dates:
  • Accepted: 30 June 2019
  • Published (online): 23 August 2019
  • Published: 23 August 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Communication Sciences (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 08 Apr 2020 12:50
Last Modified: 08 Apr 2020 13:16
Status: Published
Publisher: SAGE Publications
Refereed: Yes
Identification Number: https://doi.org/10.1177/1758835919866960
Related URLs:

Export

Statistics